Intact Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-500
| Closed | -$68.4K | – | 327 |
|
|
2025
Q1 | $68.4K | Buy |
+500
| New | +$71.5K | ﹤0.01% | 303 |
|
|
2024
Q4 | – | Sell |
-1,040
| Closed | -$202K | – | 313 |
|
|
2024
Q3 | $202K | Sell |
1,040
-2,490
| -71% | -$521K | 0.01% | 250 |
|
|
2024
Q2 | $818K | Buy |
3,530
+530
| +18% | +$115K | 0.03% | 206 |
|
|
2024
Q1 | $647K | Buy |
3,000
+700
| +30% | +$164K | 0.03% | 219 |
|
|
2023
Q4 | $595K | Buy |
+2,300
| New | +$565K | 0.02% | 220 |
|
|
2023
Q3 | – | Sell |
-1,700
| Closed | -$484K | – | 255 |
|
|
2023
Q2 | $484K | Sell |
1,700
-300
| -15% | -$89.3K | 0.02% | 231 |
|
|
2023
Q1 | $556K | Buy |
2,000
+200
| +11% | +$55.3K | 0.02% | 212 |
|
|
2022
Q4 | $498K | Sell |
1,800
-200
| -10% | -$56.5K | 0.02% | 218 |
|
|
2022
Q3 | $534K | Buy |
+2,000
| New | +$425K | 0.02% | 218 |
|
|
2019
Q2 | – | Sell |
-900
| Closed | -$213K | – | 243 |
|
|
2019
Q1 | $213K | Sell |
900
-300
| -25% | -$94.5K | 0.01% | 232 |
|
|
2018
Q4 | $361K | Hold |
1,200
| – | – | 0.01% | 191 |
|
|
2018
Q3 | $424K | Sell |
1,200
-200
| -14% | -$68.9K | 0.02% | 201 |
|
|
2018
Q2 | $406K | Hold |
1,400
| – | – | 0.01% | 191 |
|
|
2018
Q1 | $383K | Buy |
1,400
+200
| +17% | +$62.1K | 0.01% | 191 |
|
|
2017
Q4 | $382K | Hold |
1,200
| – | – | 0.02% | 171 |
|
|
2017
Q3 | $376K | Hold |
1,200
| – | – | 0.02% | 173 |
|
|
2017
Q2 | $326K | Buy |
+1,200
| New | +$317K | 0.01% | 211 |
|
|
2017
Q1 | – | Sell |
-2,400
| Closed | -$681K | – | 262 |
|
|
2016
Q4 | $681K | Sell |
2,400
-700
| -23% | -$207K | 0.03% | 174 |
|
|
2016
Q3 | $970K | Sell |
3,100
-600
| -16% | -$178K | 0.04% | 149 |
|
|
2016
Q2 | $895K | Hold |
3,700
| – | – | 0.04% | 152 |
|
|
2016
Q1 | $963K | Hold |
3,700
| – | – | 0.04% | 143 |
|
|
2015
Q4 | $1.13M | Hold |
3,700
| – | – | 0.05% | 142 |
|
|
2015
Q3 | $1.08M | Buy |
3,700
+1,200
| +48% | +$396K | 0.05% | 138 |
|
|
2015
Q2 | $1.01M | Buy |
2,500
+400
| +19% | +$161K | 0.04% | 143 |
|
|
2015
Q1 | $887K | Sell |
2,100
-1,000
| -32% | -$394K | 0.04% | 151 |
|
|
2014
Q4 | $1.05M | Hold |
3,100
| – | – | 0.04% | 144 |
|
|
2014
Q3 | $1.03M | Buy |
3,100
+400
| +15% | +$132K | 0.04% | 132 |
|
|
2014
Q2 | $851K | Buy |
+2,700
| New | +$813K | 0.03% | 130 |
|
Other funds holding BIIB
Intact Investment Management's BIIB Position: Q2 2025 in Review
Intact Investment Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 500 shares — an estimated $68.4K sold.
Intact Investment Management first reported a position in BIIB in Q2 2014 and held it in 28 quarters. The position peaked at $1.13M in Q4 2015. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- Intact Investment Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
- Intact Investment Management sold 500 Biogen shares in Q2 2025, an estimated $68.4K.
- Intact Investment Management first reported a position in Biogen in Q2 2014 and held it in 28 quarters.
- Intact Investment Management's Biogen position peaked at $1.13M in Q4 2015.
- 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on Intact Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.